| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0049-3848(89)90317-4 |
| P698 | PubMed publication ID | 2467404 |
| P50 | author | Robert Read | Q55483310 |
| P2093 | author name string | J D Pearson | |
| P G Higgins | |||
| E M Paleolog | |||
| B E Pottinger | |||
| P433 | issue | 4 | |
| P304 | page(s) | 387-394 | |
| P577 | publication date | 1989-02-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | von Willebrand factor is an acute phase reactant in man | |
| P478 | volume | 53 |
| Q64094080 | Acquired von Willebrand Syndrome Associated with Cardiovascular Diseases |
| Q28354189 | Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function |
| Q24541344 | Adhesion molecules in inflammatory bowel disease |
| Q35018544 | An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease |
| Q74387684 | Analysis of the -1185A/G von Willebrand factor (VWF) gene polymorphism in two Brazilian ethnic groups and its effect on the plasma VWF levels |
| Q72220659 | Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease |
| Q73815961 | Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters |
| Q37711406 | Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population |
| Q93591714 | Author's reply |
| Q36920462 | Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States |
| Q36144212 | Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency |
| Q92002036 | Cryptic non-canonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor |
| Q33480033 | Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis |
| Q44307967 | Differential secretion of cytokines and adhesion molecules by HUVEC stimulated with low concentrations of bleomycin |
| Q28575008 | Distribution of von Willebrand factor in capillary endothelial cells of rat lungs with pulmonary fibrosis |
| Q43861741 | Effects of Tumour Necrosis Factor and Interleukin-1 on von Willebrand Factor Secretion from Human Vascular Endothelial Cells |
| Q36944538 | Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases |
| Q36503343 | Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation |
| Q84340541 | Endothelial cell activation markers in cancer |
| Q72193746 | Endothelial cell derived factors in relation to antibodies to SSA or SSB and to endothelial cells in Sjögren's syndrome |
| Q40582594 | Endothelial cell function and thrombosis |
| Q33584025 | Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis |
| Q74172963 | Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters |
| Q38801276 | Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection |
| Q91675224 | Genetic regulation of plasma von Willebrand factor levels in health and disease |
| Q34579752 | Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. |
| Q36629977 | Hypoxia and inflammatory synovitis: observations and speculation |
| Q88814435 | Idiopathic spontaneous lesser sac haematoma: a perplexing case of abdominal apoplexy |
| Q81860346 | Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer |
| Q50860140 | Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor. |
| Q39367860 | Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation. |
| Q88984493 | Inflammation, von Willebrand factor, and ADAMTS13 |
| Q46718636 | Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study |
| Q77788575 | Malignant disease and von Willebrand factor |
| Q37276523 | Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases |
| Q37115524 | Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation |
| Q73161353 | Normal and perturbed endothelial cells from canine femoral arteries and femoral veins exhibit heterogeneity in hemostatic properties and growth characteristics |
| Q36289557 | Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery |
| Q90441308 | Physiological Roles of the von Willebrand Factor-Factor VIII Interaction |
| Q47736477 | Plasma levels of von Willebrand factor antigen in acute bronchitis and in a normal population |
| Q35010760 | Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma |
| Q35744451 | Post-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience |
| Q33565241 | Postural variation in von Willebrand factor antigen |
| Q50127476 | Recurrent Gastro-intestinal Bleeding Unfolded as Heyde's Syndrome |
| Q77357100 | Relative influence of age and thrombotic history on hemostatic parameters |
| Q42547106 | Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: do we have enough evidence? |
| Q72164287 | Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases |
| Q40683420 | Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease |
| Q38716432 | The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. |
| Q40668555 | The control of production and release of haemostatic factors in the endothelial cell |
| Q61480595 | The influence of smoking on von Willebrand factor is already manifest in healthy adolescent females: the Floren-teen (Florence Teenager) Study |
| Q26996413 | The molecular characterization of von Willebrand disease: good in parts |
| Q46658740 | Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies |
| Q73022847 | Von Willebrand factor in plasma of patients with advanced stages of larynx cancer |
| Q40997967 | von Willebrand disease in children and adolescents |
| Q26863636 | von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies |
| Q33563615 | von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis |
| Q33811903 | von Willebrand factor in iris vasculature of glaucoma patients. |
| Q40814204 | von Willebrand factor, endothelial cell damage and atherosclerosis |
Search more.